AIMD: Ainos Corp Price-to-Revenue Coefficient

Corporate company logo of Ainos Corporation (AIMD)

Ainos, Inc. relies on patents in the fields of AI respiratory diagnostics and portable testing. The company's P/S ratio helps track market value dynamics relative to revenue, with the 779.00 level representing the current value. The business adheres to bioethics and ESG standards. Growth depends on FDA certification and the scaling of capacities in the US and Taiwan.

AIMD (Ainos Corp) Price-to-Revenue Ratio history from 04/28/2023 to 11/13/2026

Ainos Corp (AIMD) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Stock Price ainos.com|AIMD - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Ainos Corp|AIMD - Total Company Value
- company book value details:
Equity per Share Ainos|AIMD - Company Book Value|Market-to-Book Ratio ainos.com|AIMD - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Ainos, Inc.|AIMD - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Ainos Corporation|AIMD - Company Aggregate Debts|Debts to Net Assets Ainos Corp|AIMD - Company Long-Term Debt|Company Short-Term Indebtedness Ainos|Quick Liquidity Indicator ainos.com
- net income and valuation multiples indicators:
AIMD - Net Income|Company Profit Forecast Ainos, Inc.|AIMD - P/E Multiple|Forward P/E Multiple Ainos Inc|AIMD - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Ainos Corp|AIMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Ainos|AIMD - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months ainos.com|AIMD - Earnings per share growth in current year|Expected earnings per share growth for next year Ainos, Inc.
- total revenue and sales volume data:
AIMD - Revenue and Sales Volume|Company Expected Sales Volume ainos.com|AIMD - P/S Multiple|Market Cap to Projected Revenue Ainos Corp
General company analysis:AIMD, ainos.com
Core merchandise of Ainos Corporation

Ainos, Inc. optimizes medical logistics through express diagnostics, which directly impacts revenue scalability. The P/S ratio measures the market value of each unit of these sales, allowing for an assessment of the premium paid for future growth. A decline in this metric signals that assets are undervalued relative to their operating turnover. The price/sales trend helps identify entry points, eliminating the risk of purchasing an asset at the peak of market optimism.

Competitors of Ainos, Inc.

P/S Multiple agilent.com (A)|P/S Multiple DGX (Quest Diagnostics Incorporated)|Price-to-Revenue Coefficient Illumina Inc (ILMN)|EXAS - Price-to-Revenue Ratio|RVTY (Revvity Corp) - Market Cap to Revenue Ratio|Bio-Rad Laboratories (BIO) - Price-to-Revenue Ratio|Price to Sales anbio.com (NNNN)|Price-to-Revenue Ratio Sotera Health|Quidel Corporation (QDEL) - Price-to-Revenue Coefficient|Market Cap to Revenue OPK (OPKO Corp)|CDNA (CareDx Health) - Market Capitalization-to-Revenue Ratio|P/S Multiple MRVI (Maravai LifeSciences)|Price-to-Revenue Coefficient fulgentgenetics.com (FLGT)|LAB - Price-to-Revenue Ratio|CTKB (Cytek Biosciences Inc) - Market Cap to Revenue Ratio|OSUR: P/S Multiple|Market Cap to Revenue Exagen|Market Cap to Revenue MDXH|luciddx.com (LUCD) - Price-to-Revenue Coefficient|P/S Multiple PRE|P/S Multiple imdxinc.com (IMDX)|P/S Multiple TRIB (Trinity Biotech)|Price-to-Revenue Coefficient ProPhase Labs Corp (PRPH)|CODX - Price-to-Revenue Ratio|heartsciences.com (HSCS) - Market Cap to Revenue|BMRA: P/S Multiple|Market Cap to Revenue Ratio CDIO|Price-to-Revenue Ratio Onconetix Corp|Market Cap to Revenue Virax Biolabs Corp (VRAX)|P/S Multiple BJDX|AWH - Price to Sales|P/S Multiple AXDX (Accelerate Diagnostics, Inc.)|CNTG: Market Cap to Revenue Ratio|Enzo - P/S Multiple|FRES - P/S Multiple|gtglabs.com (GENE) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio ME|PMD (Psychemedics Corporation) - P/S Multiple